Description

2-(5-Methyl-5,6,7,8-Tetrahydro-Benzo[4,5]Thieno-[2,3-D]Pyrimidin-4-Ylamino)-Propionic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound matters as a critical building block in the synthesis of novel, targeted therapeutic agents, offering researchers and manufacturers a reliable and well-characterized starting material. It is primarily needed by pharmaceutical R&D teams and fine chemical producers engaged in developing new drug candidates, particularly in oncology and other specialized therapeutic areas.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel small-molecule drug candidates targeting specific biological pathways.
• Oncology Research: Used in the development of potential kinase inhibitors and other targeted cancer therapies due to its fused heterocyclic core.
• Medicinal Chemistry: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Biochemical Research: Employed as a tool compound or reference standard in biochemical assays and pharmacological studies.
• Fine Chemical Synthesis: Utilized in multi-step organic syntheses to construct more complex molecular architectures for advanced applications.

Basic Information

Product Name	2-(5-Methyl-5,6,7,8-Tetrahydro-Benzo[4,5]Thieno-[2,3-D]Pyrimidin-4-Ylamino)-Propionic Acid
CAS No.	1008069-38-2
Molecular Formula	C₁₆H₁₉N₃O₂S
Molecular Weight	317.41 g/mol
Synonyms	2-[(5-Methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)amino]propanoic acid; 2-((5-Methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)amino)propionic acid; 1008069-38-2; UNII-6J9W2R4A8F; 6J9W2R4A8F; Propanoic acid, 2-[(5-methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)amino]-; BDBM50391479; AKOS025147065.
EINECS	Contact for details

Quality Control

Our 2-(5-Methyl-5,6,7,8-Tetrahydro-Benzo[4,5]Thieno-[2,3-D]Pyrimidin-4-Ylamino)-Propionic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing batch-specific results are provided and available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.